Green Formulation of Microbial Biopolyesteric Nanocarriers Toward In Vitro Drug Delivery and Its Characterization.

In the present study, formulation and characterization of microbial biopolyesteric nanocarrier (MBPNc) was reported for in vitro controlled release of the drugs, viz., amoxicillin and levofloxacin. The synthesis of microbial biopolyester, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticle was done by a triple emulsion method and loaded with amoxicillin and levofloxacin to improve its curative bioavailability. The synthesized MBPNc was found to be spherical in shape with a size range of 50-100 nm which was confirmed through Transmission Electron Microscopy (TEM) analysis. The surface topology and physicochemical characteristics were analyzed by Scanning Electron Microscopy (SEM), Fourier Transform Infrared (FTIR), and X-Ray Diffraction (XRD) spectroscopy. The cell viability % of MBPNc, amoxicillin-loaded MBPNc, and levofloxacin-loaded MBPNc on HEK293 cells at a concentration of 400 µg/ml were found to be 93.43 ± 0.66%, 92.29 ± 0.61%, and 91.53 ± 0.46%, respectively, which confirmed that MBPNc is biocompatible and can be used for biomedical applications without any cytotoxic effect. A significant decrease in the bacterial survival ratio (%) and increase in the zone of inhibition were observed on increasing the concentration of drug-loaded MBPNc against E. coli (ATCC®8739™) and S. aureus (ATCC®23,235™). The in vitro drug delivery study showed controlled release of amoxicillin (99.85 ± 0.15%) and levofloxacin (99.73 ± 0.24%) up to 22 h.